Pulmonary Tuberculosis V
Pulmonary Tuberculosis IV
Pulmonary Tuberculosis I
Pulmonary Tuberculosis III
Pulmonary Tuberculosis II
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 13, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
Swati Sharma1, Snehasish Nayak2, Bhavani R3
1Department of Microbiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India; Viral Research and Diagnostic Laboratory, Department of Virology, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna, Bihar, India.
Silico-tuberculosis (silico-TB), a severe lung disease from silica dust exposure, requires integrated control strategies. Early diagnosis via CT scans and prompt anti-TB drug therapy are crucial for managing this global health concern.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: